Reset Map2 Results
3181 S.W. Sam Jackson Park Rd.The Immune Monitoring and Cancer Omics (IMCO) Laboratories, launched by the Knight Cancer Institute in 2020, were established to provide seamless, comprehensive analytical support for clinical, translational, and basic research studies. IMCO has built an integrated infrastructure of cutting-edge assays and advanced analytics designed to comprehensively characterize immune responses, identify mechanisms of resistance, and develop predictive biomarkers for therapeutic response, risk stratification, and toxicity. In addition to supporting clinical and translational research, IMCO is deeply committed to advancing basic science. The platform provides researchers with access to state-of-the-art technologies and high-dimensional analytical capabilities to accelerate discovery and enable innovative, hypothesis-driven projects. IMCO operates as a centralized service laboratory supporting both basic researchers and clinicians. It was developed to consolidate, strengthen, and streamline translational and clinical studies involving human biospecimens. Building upon foundational scientific discoveries and innovative technologies, IMCO delivers scalable, GLP-aligned and CLIA-compliant research assays. IMCO works in close partnership with the Knight BioLibrary, the HistoPathology Shared Resource, and Knight Diagnostic Laboratories to provide integrated, end-to-end support for clinical trials addressing both correlative and primary clinical endpoints. Through collaboration with basic science laboratories and core facilities, IMCO translates scientific innovation into clinically actionable insights that ultimately benefit patients. IMCO’s current capabilities include both CLIA/CAP-certified clinical assays and research-use-only (RUO) platforms, including: • Cyclic immunofluorescence (CycIF) powered by Lunaphore COMET™ technology • Multiplex immunohistochemistry (IHC) • Olink® proximity extension assay (PEA) proteomics • NanoString GeoMx® Digital Spatial Profiling (DSP) • Mass cytometry of peripheral blood (CyTOF) • Adaptive Biotechnologies TCRβ sequencing • Single-cell RNA sequencing • Bulk RNA sequencing
2525 SW 3rd Portland , OR, 97291 United StatesThe Immune Monitoring and Cancer Omics (IMCO) Laboratories, launched by the Knight Cancer Institute in 2020, were established to provide seamless, comprehensive analytical support for clinical, translational, and basic research studies. IMCO has built an integrated infrastructure of cutting-edge assays and advanced analytics designed to comprehensively characterize immune responses, identify mechanisms of resistance, and develop predictive biomarkers for therapeutic response, risk stratification, and toxicity. In addition to supporting clinical and translational research, IMCO is deeply committed to advancing basic science. The platform provides researchers with access to state-of-the-art technologies and high-dimensional analytical capabilities to accelerate discovery and enable innovative, hypothesis-driven projects. IMCO operates as a centralized service laboratory supporting both basic researchers and clinicians. It was developed to consolidate, strengthen, and streamline translational and clinical studies involving human biospecimens. Building upon foundational scientific discoveries and innovative technologies, IMCO delivers scalable, GLP-aligned and CLIA-compliant research assays. IMCO works in close partnership with the Knight BioLibrary, the HistoPathology Shared Resource, and Knight Diagnostic Laboratories to provide integrated, end-to-end support for clinical trials addressing both correlative and primary clinical endpoints. Through collaboration with basic science laboratories and core facilities, IMCO translates scientific innovation into clinically actionable insights that ultimately benefit patients. IMCO’s current capabilities include both CLIA/CAP-certified clinical assays and research-use-only (RUO) platforms, including: • Cyclic immunofluorescence (CycIF) powered by Lunaphore COMET™ technology • Multiplex immunohistochemistry (IHC) • Olink® proximity extension assay (PEA) proteomics • NanoString GeoMx® Digital Spatial Profiling (DSP) • Mass cytometry of peripheral blood (CyTOF) • Adaptive Biotechnologies TCRβ sequencing • Single-cell RNA sequencing • Bulk RNA sequencing
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.